These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2005-005185-36 AN OPEN-LABEL PHASE III, STUDY TO EVALUATE THE SAFETY OF THE COMBINATION (FENOFIBRATE / PRAVASTATIN 160-40 MG) DURING 24 WEEKS, IN HIGH VASCULAR RISK PATIENTS WITH COMBINED HYPERLIPIDEMIA not-yet-due
Reported results 2006-001514-33 A phase III, randomized, parallel group study to compare the therapeutic efficacy of SMB BUDESONIDE-SALMETEROL DPI capsule 300/25µg BID delivered by the AXAHALER® versus SERETIDE® DISKUS® 500/50µg (Fl... 2008-03-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006557-28 A phase III, four-armed, randomised, double blind, parallel study to compare the efficacy and safety in type 2 diabetic patients with combined hyperlipidemia of a 12-week administration of Fenofibrate... 2008-10-15 bad-data
Reported results 2008-004833-70 A phase III, randomized, parallel group, open study to compare the therapeutic efficacy and safety of SMB BUDESONIDE-SALMETEROL DPI capsule 150/25μg BID delivered by the AXAHALER® versus SYMBICORT® TU... 2009-08-06 due-trials
Listed as ongoing, but also has a completion date 2010-018454-13 A Phase III, Multicentre, Randomised, Placebo-Controlled, Double Blind Study of the Incidence of Recurring Pulmonary Exacerbations in Cystic Fibrosis Patients using Two Different Doses of Inhaled Nacy... 2010-10-15 bad-data
Completed, but no date, and reported results 2010-020794-16 A phase II, randomised, partially-blinded, cross over study to evaluate the systemic effect of two doses of the SMB BUDESONIDE-SALMETEROL DPI fixed-dose combination capsule (300/25 µg BID and 150/25 µ... bad-data
Reported results 2010-023510-32 A phase IV, randomised, double-blinded, placebo-controlled, parallel study to estimate the influence of vitamin D (D-CURE®) supplementation on the 25-hydroxyvitamin D serum concentration in patients a... 2011-07-22 due-trials
Reported results 2012-000575-17 A phase III, two-armed, randomised, double blind, parallel study to compare the efficacy and safety in high CHD-risk patients with mixed dyslipidaemia of a 12-week administration of a fixed dose combi... 2015-03-16 due-trials
Reported results 2012-003417-34 A phase IV, two-armed, randomised, cross-over study to compare the compliance of a once-a-month administration of vitamin D3 (D-CURE®) to a daily administration of a fixed-dose combination of vitamin ... 2014-02-17 due-trials
Reported results 2012-004917-14 A phase IV, randomised, double-blinded, parallel study to estimate the dose-response of vitamin D (D-CURE®) supplementation on the 25-hydroxyvitamin D serum concentration in patients with vitamin D de... 2013-05-03 due-trials
Completed, but no date, and reported results 2014-003779-48 A phase IV, randomised, cross-over study to estimate the influence of food on the 25-hydroxyvitamin D3 serum level after vitamin D3 (D-CURE®) supplementation. bad-data
Reported results 2016-003755-29 A phase IV, randomised, parallel study to compare a monthly administration of vitamin D3 (D-CURE®) to a daily administration of vitamin D3 (VISTA-D3®). 2017-03-13 due-trials
Reported results 2017-002668-42 A randomised, interventional, double blind, crossover, controlled study to assess the effect of the administration of paracetamol on tramadol adverse events. 2018-02-14 due-trials
Completed, reported early 2017-003330-91 A pharmacokinetic and pharmacodynamic, randomised, single dose, cross-over, partially blinded study to compare the systemic exposure and the efficacy of a fixed-dose combination of Budesonide-Salmeter... 2018-09-30 not-yet-due